Development of oral formulations of a BCS Class II drug ezetimibe for improving ITS bioavailability and therapeutic efficacy
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Abstract is available in the Attachment
newline